about
Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of gliomaEthnicity and incidence of Hodgkin lymphoma in Canadian population.TGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development.Association between common allergic symptoms and cancer in the NHANES III female cohort.Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.Immune response in families of children with acute lymphoblastic leukaemia.Analysis of the involvement of cytokines in allergy and breast cancer association.History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin.The common cold, allergy, and cancerDecreased blood histamine levels in patients with solid malignant tumoursAtopy--a favourable prognostic factor for survival in Hodgkin's diseasePrognostic value of serum levels of immunoglobulins (IgG, IgA, IgM and IgE) in breast cancer: a preliminary study.An overview of the association between allergy and cancer.A history of allergies is associated with reduced risk of oral squamous cell carcinomaAllergy and risk of cancer. A prospective study using NHANESI followup data.Some immunological interactions between mother and foetusThe association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis.Eczema and cancer risk: a critical appraisal and review of the literature.Relationship between allergy and cancer: an overview.Cancer incidence in a general population of asthma patients.The role of IgE in the immune response to neoplasia: a review.Impaired immunoresponsiveness in tumor patients.Serum immunoglobulins in breast cancer.Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer.Comparative incidence of allergy in the presence or absence of cancer.Is allergen skin test reactivity a predictor of mortality? Findings from a national cohort.Books and Monographs: Recent Results in Cancer Research.Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus.
P2860
Q29248257-D58A3DB5-6514-4A24-97F8-1979EFA3C76BQ33443545-2AC93577-2211-4647-8D5F-BF19BC6D3398Q33809976-78166728-E20C-450A-A6D4-032C215D7C8BQ34426740-8D420353-8B51-4E54-8ED4-5FD84C6F4AF9Q34676844-AA676254-CD75-4C9A-A5E0-2C743EA75439Q35150565-9AD3FBBB-EB4F-4C1F-BDF6-498414537831Q35165566-7A8B6FF2-43C9-49A5-B697-7BAE99EA2BE2Q35251787-DF9750CC-FDD6-40DF-A21B-471B08BF8F65Q36027831-CEF151F3-F5A2-44D4-8771-44B1018D0AEAQ36047585-FBA7C436-9D4D-48AA-A889-39E419FE6B10Q36047924-7AC7CA44-93B2-45F9-9911-8BAD67C87C37Q36069135-7E59AFFA-9A7B-44AC-9BFF-9421FF7A5707Q36361728-26625839-9670-4157-9E06-F06B4718A515Q36403705-090D293A-1263-4DA2-BBA9-09AD6456F3CEQ36452818-DE525BFC-3E20-40C2-8B23-7C4974A8E52BQ36883555-E72A2C80-052C-4ADD-B1A3-83A912F84365Q37429981-BF950C3E-887C-464A-B4CD-2DB22F209AB7Q37925037-28346CF4-BCD5-4B8A-93F9-F0B1D16D2B6EQ38020690-FF2E99EB-344D-48DA-BFC7-1C30F999F438Q38470959-A09D34D2-6D7B-4860-A3AD-289E2D4E5798Q39416499-2A2C6ACB-68CB-42D5-890C-13A1630A16A1Q39939888-753834E0-97D2-42AC-AD1D-A2038F8212A5Q41025657-15DE8013-5E1D-4CF6-9D71-5BBA9413BACBQ44049814-06FF99FA-5639-4F89-B6F8-F3B43A7BFFBDQ44389698-0856CC82-BB77-46DA-9EA4-1D08F88E5763Q44434567-0F4F43B4-0834-4137-9774-AA7779F309D1Q45804459-619D947D-8450-411C-8F2A-4CAFA6E07038Q45861240-1F31E11A-D2A7-4367-B5E7-0D8EDC44F2C6
P2860
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年論文
@yue
1966年論文
@zh-hant
1966年論文
@zh-hk
1966年論文
@zh-mo
1966年論文
@zh-tw
1966年论文
@wuu
1966年论文
@zh
1966年论文
@zh-cn
name
The incidence of allergic disorders and cancer.
@ast
The incidence of allergic disorders and cancer.
@en
type
label
The incidence of allergic disorders and cancer.
@ast
The incidence of allergic disorders and cancer.
@en
prefLabel
The incidence of allergic disorders and cancer.
@ast
The incidence of allergic disorders and cancer.
@en
P2860
P356
P1476
The incidence of allergic disorders and cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1966.52
P407
P577
1966-09-01T00:00:00Z